PROSTACOX : Metastatic Prostate Chemotherapy

University Hospital, Rouen52 enrolled

Overview

Clinical response to chemotherapy. Biological parameter (PSA) and RECIST evaluation. Association of Docetaxel (J 15) and Celecoxib.

Association Docetaxel (J 15) and celecoxib Patient survival Biological parameter : PSA Clinical status RECIST evaluation

Study Type

OBSERVATIONAL

Enrollment

Sex: MALE

Medical Language ↔ Plain English

Inclusion Criteria: * metastatic prostate cancer * ASCO progression criteria Exclusion Criteria: * other prostate chemotherapy

Charles Nicolle, University Hospital

Rouen, France

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.